Clinical study on the treatment of liver fibrosis due to hepatitis B by IFN-α1 and traditional medicine preparation

Table 1 Comparison of the 5 serum indexes of the 40 patients before and after treatment and after 6 months of follow-up (^-x±s)

Time	n	LN	PCIII	HA (ng/L)	Albumin	Globulin
		(ng/L)			(g/L)
Before treatment	40	420.0 ± 68.0	146.2 ± 44.8	182.40 ± 42.20	30.51 ± 2.42	26.25 ± 6.84
After treatment	40	290.3 ± 36.4b	112.4 ± 30.6b	136.32 ± 39.20b	35.25 ± 4.46b	31.32 ± 6.74b
Effective type after 6 months follow-up	22	142.6 ± 32.8c	80.0 ± 31.8c	84.54 ± 36.33c	39.13 ± 3.24c	25.98 ± 3.22c
Non-effective type after 6 months follow-up	18	403.5 ± 41.5a	156.3 ± 43.9a	178.20 ± 38.60a	29.35 ± 2.71a	37.00 ± 4.54a

^aP < 0.05;

^bP < 0.001, compared with those before treatment;

^cP < 0.001 the effective type compared with the non-effective type.